Global Sleep Apnea
Synopsis:
Global Sleep Apnea Devices Market is expected to reach USD 7.1 billion by 2024, at a CAGR 7.8% during the forecast period of 2017 to 2024. The report contains 326 pages of exclusive premium insights with 347 tables and 30 figures.
Globally, there is an exponential rise in the cases of Obstructive Sleep Apnea (OSA) among the world population and is one of the most important factors contributing to the growth of this market. It is estimated that around 100 million people suffer from OSA across the world. Factors which cause development of sleep apnea include obesity, life style habits such as smoking, alcohol, irregular sleep patterns, and substance abuse. The risk of sleep apnea is higher in the age group above 50-60 years. It is found that more than 18 million adults across different age groups have sleep apnea and approx two to three percent cases are related to childhood OSA. The numbers are much higher in children with habitual snoring. The most common conditions associated with this disorder include atrial fibrillation, coronary artery disease, respiratory diseases, stroke, congestive heart failure, obesity, and hypertension and type II diabetes.
The global sleep apnea devices market has been segmented On the basis of product type into Diagnostic Devices, and Therapeutic Devices. Diagnostic Devices is further segmented into Polysomnographs, Pulse Oximeters, Polygraphs, and Actygraph.
Based on end-user the market is segmented into Hospitals, Home Healthcare, Sleep Clinics, and Community Healthcare.
Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.
Major Players Operating in this market:
Philips Respironics, a subsidiary of Philips Healthcare; ResMed; Fisher and Paykel Healthcare, Ltd. (New Zealand); Compumedics Limited (Australia), Carefusion Corporation (U.S.), Curative Medical, Inc., BMC Medical Co., Ltd., Natus Medical Incorporated, DeVilbiss Healthcare, Global Medical Holdings, LLC, Itamar Medical, Ltd., and Weinmann Medical Devices GmbH & Co. KG among others.
Regions Covered In The Scope Of The Report:
Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa (South Africa, Rest of MEA))
Global Sleep Apnea Devices Market is expected to reach USD 7.1 billion by 2024, at a CAGR 7.8% during the forecast period of 2017 to 2024. The report contains 326 pages of exclusive premium insights with 347 tables and 30 figures.
Globally, there is an exponential rise in the cases of Obstructive Sleep Apnea (OSA) among the world population and is one of the most important factors contributing to the growth of this market. It is estimated that around 100 million people suffer from OSA across the world. Factors which cause development of sleep apnea include obesity, life style habits such as smoking, alcohol, irregular sleep patterns, and substance abuse. The risk of sleep apnea is higher in the age group above 50-60 years. It is found that more than 18 million adults across different age groups have sleep apnea and approx two to three percent cases are related to childhood OSA. The numbers are much higher in children with habitual snoring. The most common conditions associated with this disorder include atrial fibrillation, coronary artery disease, respiratory diseases, stroke, congestive heart failure, obesity, and hypertension and type II diabetes.
The global sleep apnea devices market has been segmented On the basis of product type into Diagnostic Devices, and Therapeutic Devices. Diagnostic Devices is further segmented into Polysomnographs, Pulse Oximeters, Polygraphs, and Actygraph.
Based on end-user the market is segmented into Hospitals, Home Healthcare, Sleep Clinics, and Community Healthcare.
Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.
Major Players Operating in this market:
Philips Respironics, a subsidiary of Philips Healthcare; ResMed; Fisher and Paykel Healthcare, Ltd. (New Zealand); Compumedics Limited (Australia), Carefusion Corporation (U.S.), Curative Medical, Inc., BMC Medical Co., Ltd., Natus Medical Incorporated, DeVilbiss Healthcare, Global Medical Holdings, LLC, Itamar Medical, Ltd., and Weinmann Medical Devices GmbH & Co. KG among others.
Regions Covered In The Scope Of The Report:
Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa (South Africa, Rest of MEA))
1 INTRODUCTION
1.1. OVERVIEW OF THE SLEEP APNEA DEVICES MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
2 RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL SLEEP APNEA DEVICES MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.2.7. PEST ANALYSIS
2.4. GLOBAL SLEEP APNEA DEVICES MARKET: RESEARCH SNAPSHOT
2.3. ASSUMPTIONS
3 MARKET LANDSCAPE SUMMARY
4 PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. SLEEP APNEA DEVICES MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5 SLEEP APNEA DEVICES MARKET, BY TYPE
5.1. OVERVIEW
5.2. SLEEP APNEA THERAPEUTIC DEVICES
5.2. SLEEP APNEA DIAGNOSTIC DEVICES
6 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. POSITIVE AIRWAY PRESSURE DEVICES MARKET (PAP)
6.2.1. CONTINUOUS AIRWAY PRESSURE DEVICES MARKET (CPAP)
6.2.2. BI-LEVEL AIRWAY PRESSURE DEVICES MARKET (BIPAP)
6.2.3. VARIABLE POSITIVE AIRWAY PRESSURE (VPAP)
6.2.4. AUTOMATICALLY-ADJUSTING POSITIVE AIRWAY PRESSURE (APAP)
6.3. MASKS
6.3.1. NON-VENTED MASKS
6.3.2. NASAL MASKS
6.3.3. NASAL PILLOWS
6.3.4. FULL FACE MASKS
6.3.5. PAEDIATRIC MASKS
6.3.6. OTHERS
6.4. ADAPTIVE SERVO-VENTILATION (ASV)
6.5. AIRWAY CLEARANCE SYSTEMS
6.6. OXYGEN CONCENTRATORS
6.6.1. STATIONARY CONCENTRATORS
6.6.2. PORTABLE CONCENTRATORS
6.7. ORAL SLEEP APNEA DEVICES
6.7.1. MANDIBULAR ADVANCEMENT DEVICES (MAD)
6.7.2. TONGUE RETAINING DEVICE (TRD)
6.8. ACCESSORIES
7 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT TYPE
7.1. OVERVIEW
7.2. PULSE OXIMETERS
7.2.1. HANDHELD PULSE OXIMETERS
7.2.2. FINGERTIP PULSE OXIMETERS
7.2.3. TABLETOP PULSE OXIMETERS
7.2.4. WRIST-WORN PULSE OXIMETERS
7.3. POLYSOMNOGRAPH (PSG)
7.3.1. CLINICAL PSG
7.3.2. AMBULATORY PSG DEVICES
7.4. RESPIRATORY POLYGRAPH
7.5. ACTIGRAPH
8 SLEEP APNEA DEVICES MARKET, BY END USER
8.1. OVERVIEW
8.2. DIAGNOSTIC DEVICES
8.2.1. HOSPITALS
8.2.2. HOME HEALTHCARE
8.2.3. SLEEP CLINICS
8.2.4. COMMUNITY HEALTHCARE
8.3. THERAPEUTIC DEVICES
8.3.1. HOSPITALS
8.3.2. HOME HEALTHCARE
8.3.3. SLEEP CLINICS
8.3.4. COMMUNITY HEALTHCARE
9 SLEEP APNEA DEVICES MARKET, BY APNEA TYPE
9.1. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY APNEA TYPE
9.1.1. OBSTRUCTIVE SLEEP APNEA
9.1.2. CENTRAL SLEEP APNEA
9.1.3. COMPLEX SLEEP APNEA
9.2. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY APNEA TYPE
9.2.1. OBSTRUCTIVE SLEEP APNEA
9.2.2. CENTRAL SLEEP APNEA
9.3.3. COMPLEX SLEEP APNEA
9.3. SLEEP APNEA PATIENT VOLUME, BY APNEA TYPE
9.3.1. OBSTRUCTIVE SLEEP APNEA
9.3.2. CENTRAL SLEEP APNEA
9.3.3. COMPLEX SLEEP APNEA
10 SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY
10.1. COUNTRYWISE SLEEP APNEA DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
10.1.1. NORTH AMERICA
10.1.1.1. U.S.
10.1.1.2. CANADA
10.1.1.3. MEXICO
10.1.2. EUROPE
10.1.2.1. GERMANY
10.1.2.2. FRANCE
10.1.2.3. U.K.
10.1.2.4. ITALY
10.1.2.5. SPAIN
10.1.2.6. RUSSIA
10.1.2.7. TURKEY
10.1.2.8. BELGIUM
10.1.2.9. NETHERLANDS
10.1.2.7. SWITZERLAND
10.1.2.11. REST OF EUROPE
10.1.3. ASIA-PACIFIC (APAC)
10.1.3.1. JAPAN
10.1.3.2. CHINA
10.1.3.3. SOUTH KOREA
10.1.3.4. INDIA
10.1.3.5. AUSTRALIA
10.1.3.6. SINGAPORE
10.1.3.7. THAILAND
10.1.3.8. MALAYSIA
10.1.3.9. INDONESIA
10.1.3.10. PHILIPPINES
10.1.3.11. REST OF APAC
10.1.4. SOUTH AMERICA
10.1.4.1. BRAZIL
10.1.4.2. REST OF LATIN AMERICA
10.1.5. MIDDLE EAST AND AFRICA
10.1.5.1. SAUDI ARABIA
10.1.5.2. REST OF MIDDLE EAST AND AFRICA
10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11 SLEEP APNEA DEVICES MARKET: COMPETITIVE LANDSCAPE
11.1. GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.2. GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.3. U.S. SLEEP APNEA THERAPEUTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.4. U.S. SLEEP APNEA DIAGNOSTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.5. EUROPE SLEEP APNEA THERAPEUTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.6. EUROPE SLEEP APNEA DIAGNOSTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.7. APAC SLEEP APNEA THERAPEUTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.8. APAC SLEEP APNEA DIAGNOSTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.9. MERGERS & ACQUISITIONS
11.10. NEW PRODUCT DEVELOPMENT & APPROVALS
11.11. EXPANSIONS
11.12. REGULATORY CHANGES
11.13. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12 SLEEP APNEA DEVICES MARKET, COMPANY PROFILES
12.1 PHILIPS RESPIRONICS
12.1.1 OVERVIEW
12.1.2 SWOT ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 REVENUE ANALYSIS
12.1.5 ANALYSTS VIEW
12.2 RESMED
12.2.1 OVERVIEW
12.2.2 SWOT ANALYSIS
12.2.3 PRODUCT PORTFOLIO
12.2.4 REVENUE ANALYSIS
12.2.5 ANALYSTS VIEW
12.3 FISHER AND PAYKEL HEALTHCARE, LTD.
12.3.1 OVERVIEW
12.3.2 SWOT ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 REVENUE ANALYSIS
12.3.5 ANALYST VIEW
12.4 COMPUMEDICS LIMITED
12.4.1 OVERVIEW
12.4.2 SWOT ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 REVENUE ANALYSIS
12.4.5 ANALYSTS VIEW
12.5 SOMNOMED
12.5.1 OVERVIEW
12.5.2 SWOT ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 REVENUE ANALYSIS
12.5.5 ANALYSTS VIEW
12.6 CAREFUSION CORPORATION
12.6.1 OVERVIEW
12.6.2 SWOT ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 REVENUE ANALYSIS
12.6.5 ANALYSTS VIEW
12.7 CURATIVE MEDICAL, INC.
12.7.1 OVERVIEW
12.7.2 SWOT ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 REVENUE ANALYSIS
12.7.5 ANALYSTS VIEW
12.8 BMC MEDICAL, CO. LTD.
12.8.1 OVERVIEW
12.8.2 SWOT ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 REVENUE ANALYSIS
12.1.5 ANALYSTS VIEW
12.9 NATUS MEDICAL, INC.
12.9.1 OVERVIEW
12.9.2 SWOT ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 REVENUE ANALYSIS
12.9.5 ANALYSTS VIEW
12.10 DEVILBISS HEALTHCARE
12.10.1 OVERVIEW
12.10.2 SWOT ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 REVENUE ANALYSIS
12.10.5 ANALYSTS VIEW
12.11 GLOBAL MEDICAL HOLDINGS, LLC
12.11.1 OVERVIEW
12.11.2 SWOT ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 REVENUE ANALYSIS
12.11.5 ANALYSTS VIEW
12.12 ITAMAR MEDICAL, LTD.
12.12.1 OVERVIEW
12.12.2 SWOT ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 REVENUE ANALYSIS
12.12.5 ANALYSTS VIEW
12.13 WEINMANN MEDICAL DEVICES GMBH & CO. KG
12.13.1 OVERVIEW
12.13.2 SWOT ANALYSIS
12.13.3 PRODUCT PORTFOLIO
12.13.4 REVENUE ANALYSIS
12.13.5 ANALYSTS VIEW
12.14 SIBELGROUP
12.14.1 OVERVIEW
12.14.2 SWOT ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 REVENUE ANALYSIS
12.14.5 ANALYSTS VIEW
12.15 AMBULATORY MONITORING, INC.
12.15.1 OVERVIEW
12.15.2 SWOT ANALYSIS
12.15.3 PRODUCT PORTFOLIO
12.15.4 REVENUE ANALYSIS
12.15.5 ANALYSTS VIEW
12.16 MEDICOM MTD, LTD.
12.16.1 OVERVIEW
12.16.2 SWOT ANALYSIS
12.16.3 PRODUCT PORTFOLIO
12.16.4 REVENUE ANALYSIS
12.16.5 ANALYSTS VIEW
12.17 CUSTO MED GMBH
12.17.1 OVERVIEW
12.17.2 SWOT ANALYSIS
12.17.3 PRODUCT PORTFOLIO
12.17.4 REVENUE ANALYSIS
12.17.5 ANALYSTS VIEW
12.18 HEINEN LOWENSTEIN GMBH & CO. KG
12.18.1 OVERVIEW
12.18.2 SWOT ANALYSIS
12.18.3 PRODUCT PORTFOLIO
12.18.4 REVENUE ANALYSIS
12.18.5 ANALYSTS VIEW
12.19 ERGOLINE GMBH
12.19.1 OVERVIEW
12.19.2 SWOT ANALYSIS
12.19.3 PRODUCT PORTFOLIO
12.19.4 REVENUE ANALYSIS
12.19.5 ANALYSTS VIEW
12.20 NEUROVIRTUAL
12.20.1 OVERVIEW
12.20.2 SWOT ANALYSIS
12.20.3 PRODUCT PORTFOLIO
12.20.4 REVENUE ANALYSIS
12.20.5 ANALYSTS VIEW
12.21 BMC MEDICAL CO., LTD.
12.21.1 OVERVIEW
12.21.2 SWOT ANALYSIS
12.21.3 PRODUCT PORTFOLIO
12.21.4 REVENUE ANALYSIS
12.21.5 ANALYSTS VIEW
12.22 SOMNOMEDICS GMBH
12.22.1 OVERVIEW
12.22.2 SWOT ANALYSIS
12.22.3 PRODUCT PORTFOLIO
12.22.4 REVENUE ANALYSIS
12.22.5 ANALYSTS VIEW
12.23 CONTEC MEDICAL SYSTEMS CO.,LTD.
12.23.1 OVERVIEW
12.23.2 SWOT ANALYSIS
12.23.3 PRODUCT PORTFOLIO
12.23.4 REVENUE ANALYSIS
12.23.5 ANALYSTS VIEW
12.24 CLEVELAND MEDICAL DEVICES INC.
12.24.1 OVERVIEW
12.24.2 SWOT ANALYSIS
12.24.3 PRODUCT PORTFOLIO
12.24.4 REVENUE ANALYSIS
12.24.5 ANALYSTS VIEW
12.25 SOMNETICS INTERNATIONAL, INC.
12.25.1 OVERVIEW
12.25.2 SWOT ANALYSIS
12.25.3 PRODUCT PORTFOLIO
12.25.4 REVENUE ANALYSIS
12.24.5 ANALYSTS VIEW
13 APPENDIX
13.1 RELATED REPORTS
13.2 CUSTOMIZABLE OPTIONS
13.3 SOURCE SHEET
13.3 BIBLIOGRAPHY
14 ABOUT DATA BRIDGE MARKET RESEARCH
1.1. OVERVIEW OF THE SLEEP APNEA DEVICES MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
2 RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL SLEEP APNEA DEVICES MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.2.7. PEST ANALYSIS
2.4. GLOBAL SLEEP APNEA DEVICES MARKET: RESEARCH SNAPSHOT
2.3. ASSUMPTIONS
3 MARKET LANDSCAPE SUMMARY
4 PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. SLEEP APNEA DEVICES MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5 SLEEP APNEA DEVICES MARKET, BY TYPE
5.1. OVERVIEW
5.2. SLEEP APNEA THERAPEUTIC DEVICES
5.2. SLEEP APNEA DIAGNOSTIC DEVICES
6 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. POSITIVE AIRWAY PRESSURE DEVICES MARKET (PAP)
6.2.1. CONTINUOUS AIRWAY PRESSURE DEVICES MARKET (CPAP)
6.2.2. BI-LEVEL AIRWAY PRESSURE DEVICES MARKET (BIPAP)
6.2.3. VARIABLE POSITIVE AIRWAY PRESSURE (VPAP)
6.2.4. AUTOMATICALLY-ADJUSTING POSITIVE AIRWAY PRESSURE (APAP)
6.3. MASKS
6.3.1. NON-VENTED MASKS
6.3.2. NASAL MASKS
6.3.3. NASAL PILLOWS
6.3.4. FULL FACE MASKS
6.3.5. PAEDIATRIC MASKS
6.3.6. OTHERS
6.4. ADAPTIVE SERVO-VENTILATION (ASV)
6.5. AIRWAY CLEARANCE SYSTEMS
6.6. OXYGEN CONCENTRATORS
6.6.1. STATIONARY CONCENTRATORS
6.6.2. PORTABLE CONCENTRATORS
6.7. ORAL SLEEP APNEA DEVICES
6.7.1. MANDIBULAR ADVANCEMENT DEVICES (MAD)
6.7.2. TONGUE RETAINING DEVICE (TRD)
6.8. ACCESSORIES
7 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT TYPE
7.1. OVERVIEW
7.2. PULSE OXIMETERS
7.2.1. HANDHELD PULSE OXIMETERS
7.2.2. FINGERTIP PULSE OXIMETERS
7.2.3. TABLETOP PULSE OXIMETERS
7.2.4. WRIST-WORN PULSE OXIMETERS
7.3. POLYSOMNOGRAPH (PSG)
7.3.1. CLINICAL PSG
7.3.2. AMBULATORY PSG DEVICES
7.4. RESPIRATORY POLYGRAPH
7.5. ACTIGRAPH
8 SLEEP APNEA DEVICES MARKET, BY END USER
8.1. OVERVIEW
8.2. DIAGNOSTIC DEVICES
8.2.1. HOSPITALS
8.2.2. HOME HEALTHCARE
8.2.3. SLEEP CLINICS
8.2.4. COMMUNITY HEALTHCARE
8.3. THERAPEUTIC DEVICES
8.3.1. HOSPITALS
8.3.2. HOME HEALTHCARE
8.3.3. SLEEP CLINICS
8.3.4. COMMUNITY HEALTHCARE
9 SLEEP APNEA DEVICES MARKET, BY APNEA TYPE
9.1. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY APNEA TYPE
9.1.1. OBSTRUCTIVE SLEEP APNEA
9.1.2. CENTRAL SLEEP APNEA
9.1.3. COMPLEX SLEEP APNEA
9.2. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY APNEA TYPE
9.2.1. OBSTRUCTIVE SLEEP APNEA
9.2.2. CENTRAL SLEEP APNEA
9.3.3. COMPLEX SLEEP APNEA
9.3. SLEEP APNEA PATIENT VOLUME, BY APNEA TYPE
9.3.1. OBSTRUCTIVE SLEEP APNEA
9.3.2. CENTRAL SLEEP APNEA
9.3.3. COMPLEX SLEEP APNEA
10 SLEEP APNEA DEVICES MARKET, BY GEOGRAPHY
10.1. COUNTRYWISE SLEEP APNEA DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
10.1.1. NORTH AMERICA
10.1.1.1. U.S.
10.1.1.2. CANADA
10.1.1.3. MEXICO
10.1.2. EUROPE
10.1.2.1. GERMANY
10.1.2.2. FRANCE
10.1.2.3. U.K.
10.1.2.4. ITALY
10.1.2.5. SPAIN
10.1.2.6. RUSSIA
10.1.2.7. TURKEY
10.1.2.8. BELGIUM
10.1.2.9. NETHERLANDS
10.1.2.7. SWITZERLAND
10.1.2.11. REST OF EUROPE
10.1.3. ASIA-PACIFIC (APAC)
10.1.3.1. JAPAN
10.1.3.2. CHINA
10.1.3.3. SOUTH KOREA
10.1.3.4. INDIA
10.1.3.5. AUSTRALIA
10.1.3.6. SINGAPORE
10.1.3.7. THAILAND
10.1.3.8. MALAYSIA
10.1.3.9. INDONESIA
10.1.3.10. PHILIPPINES
10.1.3.11. REST OF APAC
10.1.4. SOUTH AMERICA
10.1.4.1. BRAZIL
10.1.4.2. REST OF LATIN AMERICA
10.1.5. MIDDLE EAST AND AFRICA
10.1.5.1. SAUDI ARABIA
10.1.5.2. REST OF MIDDLE EAST AND AFRICA
10.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11 SLEEP APNEA DEVICES MARKET: COMPETITIVE LANDSCAPE
11.1. GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.2. GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.3. U.S. SLEEP APNEA THERAPEUTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.4. U.S. SLEEP APNEA DIAGNOSTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.5. EUROPE SLEEP APNEA THERAPEUTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.6. EUROPE SLEEP APNEA DIAGNOSTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.7. APAC SLEEP APNEA THERAPEUTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.8. APAC SLEEP APNEA DIAGNOSTIC DEVICES MARKET: COMPANY SHARE ANALYSIS
11.9. MERGERS & ACQUISITIONS
11.10. NEW PRODUCT DEVELOPMENT & APPROVALS
11.11. EXPANSIONS
11.12. REGULATORY CHANGES
11.13. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12 SLEEP APNEA DEVICES MARKET, COMPANY PROFILES
12.1 PHILIPS RESPIRONICS
12.1.1 OVERVIEW
12.1.2 SWOT ANALYSIS
12.1.3 PRODUCT PORTFOLIO
12.1.4 REVENUE ANALYSIS
12.1.5 ANALYSTS VIEW
12.2 RESMED
12.2.1 OVERVIEW
12.2.2 SWOT ANALYSIS
12.2.3 PRODUCT PORTFOLIO
12.2.4 REVENUE ANALYSIS
12.2.5 ANALYSTS VIEW
12.3 FISHER AND PAYKEL HEALTHCARE, LTD.
12.3.1 OVERVIEW
12.3.2 SWOT ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 REVENUE ANALYSIS
12.3.5 ANALYST VIEW
12.4 COMPUMEDICS LIMITED
12.4.1 OVERVIEW
12.4.2 SWOT ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 REVENUE ANALYSIS
12.4.5 ANALYSTS VIEW
12.5 SOMNOMED
12.5.1 OVERVIEW
12.5.2 SWOT ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 REVENUE ANALYSIS
12.5.5 ANALYSTS VIEW
12.6 CAREFUSION CORPORATION
12.6.1 OVERVIEW
12.6.2 SWOT ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 REVENUE ANALYSIS
12.6.5 ANALYSTS VIEW
12.7 CURATIVE MEDICAL, INC.
12.7.1 OVERVIEW
12.7.2 SWOT ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 REVENUE ANALYSIS
12.7.5 ANALYSTS VIEW
12.8 BMC MEDICAL, CO. LTD.
12.8.1 OVERVIEW
12.8.2 SWOT ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 REVENUE ANALYSIS
12.1.5 ANALYSTS VIEW
12.9 NATUS MEDICAL, INC.
12.9.1 OVERVIEW
12.9.2 SWOT ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 REVENUE ANALYSIS
12.9.5 ANALYSTS VIEW
12.10 DEVILBISS HEALTHCARE
12.10.1 OVERVIEW
12.10.2 SWOT ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 REVENUE ANALYSIS
12.10.5 ANALYSTS VIEW
12.11 GLOBAL MEDICAL HOLDINGS, LLC
12.11.1 OVERVIEW
12.11.2 SWOT ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 REVENUE ANALYSIS
12.11.5 ANALYSTS VIEW
12.12 ITAMAR MEDICAL, LTD.
12.12.1 OVERVIEW
12.12.2 SWOT ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 REVENUE ANALYSIS
12.12.5 ANALYSTS VIEW
12.13 WEINMANN MEDICAL DEVICES GMBH & CO. KG
12.13.1 OVERVIEW
12.13.2 SWOT ANALYSIS
12.13.3 PRODUCT PORTFOLIO
12.13.4 REVENUE ANALYSIS
12.13.5 ANALYSTS VIEW
12.14 SIBELGROUP
12.14.1 OVERVIEW
12.14.2 SWOT ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 REVENUE ANALYSIS
12.14.5 ANALYSTS VIEW
12.15 AMBULATORY MONITORING, INC.
12.15.1 OVERVIEW
12.15.2 SWOT ANALYSIS
12.15.3 PRODUCT PORTFOLIO
12.15.4 REVENUE ANALYSIS
12.15.5 ANALYSTS VIEW
12.16 MEDICOM MTD, LTD.
12.16.1 OVERVIEW
12.16.2 SWOT ANALYSIS
12.16.3 PRODUCT PORTFOLIO
12.16.4 REVENUE ANALYSIS
12.16.5 ANALYSTS VIEW
12.17 CUSTO MED GMBH
12.17.1 OVERVIEW
12.17.2 SWOT ANALYSIS
12.17.3 PRODUCT PORTFOLIO
12.17.4 REVENUE ANALYSIS
12.17.5 ANALYSTS VIEW
12.18 HEINEN LOWENSTEIN GMBH & CO. KG
12.18.1 OVERVIEW
12.18.2 SWOT ANALYSIS
12.18.3 PRODUCT PORTFOLIO
12.18.4 REVENUE ANALYSIS
12.18.5 ANALYSTS VIEW
12.19 ERGOLINE GMBH
12.19.1 OVERVIEW
12.19.2 SWOT ANALYSIS
12.19.3 PRODUCT PORTFOLIO
12.19.4 REVENUE ANALYSIS
12.19.5 ANALYSTS VIEW
12.20 NEUROVIRTUAL
12.20.1 OVERVIEW
12.20.2 SWOT ANALYSIS
12.20.3 PRODUCT PORTFOLIO
12.20.4 REVENUE ANALYSIS
12.20.5 ANALYSTS VIEW
12.21 BMC MEDICAL CO., LTD.
12.21.1 OVERVIEW
12.21.2 SWOT ANALYSIS
12.21.3 PRODUCT PORTFOLIO
12.21.4 REVENUE ANALYSIS
12.21.5 ANALYSTS VIEW
12.22 SOMNOMEDICS GMBH
12.22.1 OVERVIEW
12.22.2 SWOT ANALYSIS
12.22.3 PRODUCT PORTFOLIO
12.22.4 REVENUE ANALYSIS
12.22.5 ANALYSTS VIEW
12.23 CONTEC MEDICAL SYSTEMS CO.,LTD.
12.23.1 OVERVIEW
12.23.2 SWOT ANALYSIS
12.23.3 PRODUCT PORTFOLIO
12.23.4 REVENUE ANALYSIS
12.23.5 ANALYSTS VIEW
12.24 CLEVELAND MEDICAL DEVICES INC.
12.24.1 OVERVIEW
12.24.2 SWOT ANALYSIS
12.24.3 PRODUCT PORTFOLIO
12.24.4 REVENUE ANALYSIS
12.24.5 ANALYSTS VIEW
12.25 SOMNETICS INTERNATIONAL, INC.
12.25.1 OVERVIEW
12.25.2 SWOT ANALYSIS
12.25.3 PRODUCT PORTFOLIO
12.25.4 REVENUE ANALYSIS
12.24.5 ANALYSTS VIEW
13 APPENDIX
13.1 RELATED REPORTS
13.2 CUSTOMIZABLE OPTIONS
13.3 SOURCE SHEET
13.3 BIBLIOGRAPHY
14 ABOUT DATA BRIDGE MARKET RESEARCH
